Suppr超能文献

中国广州气道铜绿假单胞菌分离与感染对稳定期支气管扩张的影响。

Effect of airway Pseudomonas aeruginosa isolation and infection on steady-state bronchiectasis in Guangzhou, China.

作者信息

Guan Wei-Jie, Gao Yong-Hua, Xu Gang, Lin Zhi-Ya, Tang Yan, Li Hui-Min, Li Zhi-Min, Zheng Jin-Ping, Chen Rong-Chang, Zhong Nan-Shan

机构信息

1 State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510120, China ; 2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China ; 3 Guangzhou First People's Hospital, Guangzhou 510120, China.

出版信息

J Thorac Dis. 2015 Apr;7(4):625-36. doi: 10.3978/j.issn.2072-1439.2015.04.04.

Abstract

BACKGROUND

Current status of Pseudomonas aeruginosa (PA) infection in clinically stable bronchiectasis in mainland China remains unclear.

OBJECTIVE

To compare the inflammation and lung function impairment in bronchiectasis patients isolated or infected with PA, potentially pathogenic microorganisms (PPMs) and commensals, and to identify factors associated with PA isolation and infection.

METHODS

Patients with steady-state bronchiectasis and healthy subjects were recruited. Peripheral blood and sputum were sampled to determine inflammatory markers and bacterial loads in steady-state bronchiectasis and health. Spirometry and diffusing capacity were also measured.

RESULTS

We enrolled 144 bronchiectasis patients and 23 healthy subjects. PA isolation and infection accounted for 44 and 39 patients, who demonstrated significant inflammatory responses and markedly impaired spirometry, but not diffusing capacity, compared with healthy subjects and patients isolated with other PPMs and commensals (all P<0.05). Except for heightened sputum inflammatory responses, there were no notable differences in serum inflammation and lung function as with the increased density of PA. Female gender [odds ratio (OR): 3.10 for PA isolation; OR: 3.74 for PA infection], 4 or more exacerbations within 2 years (OR: 3.74 for PA isolation, OR: 2.95 for PA infection) and cystic bronchiectasis (OR: 3.63 for PA isolation, OR: 4.47 for PA infection) were the factors consistently associated with PA isolation and infection.

CONCLUSIONS

PA elicits intense inflammation and lung function impairment in steady-state bronchiectasis. The density of PA does not correlate with most clinical indices. PA infection is associated with females, frequent exacerbations and cystic bronchiectasis.

摘要

背景

中国大陆临床稳定的支气管扩张症患者中铜绿假单胞菌(PA)感染的现状仍不清楚。

目的

比较支气管扩张症患者中分离出PA、潜在致病微生物(PPM)和共生菌或感染这些病菌后的炎症反应和肺功能损害情况,并确定与PA分离和感染相关的因素。

方法

招募病情稳定的支气管扩张症患者和健康受试者。采集外周血和痰液样本,以确定病情稳定的支气管扩张症患者和健康受试者的炎症标志物和细菌载量。同时测量肺活量和弥散功能。

结果

我们纳入了144例支气管扩张症患者和23名健康受试者。PA分离和感染分别涉及44例和39例患者,与健康受试者以及分离出其他PPM和共生菌的患者相比,这些患者表现出显著的炎症反应,肺活量测定明显受损,但弥散功能未受影响(所有P<0.05)。除痰液炎症反应增强外,血清炎症和肺功能与PA密度增加无显著差异。女性[比值比(OR):PA分离为3.10;PA感染为3.74]、2年内发作4次或更多次(OR:PA分离为3.74,PA感染为2.95)和囊状支气管扩张(OR:PA分离为3.63,PA感染为4.47)是与PA分离和感染始终相关的因素。

结论

PA在病情稳定的支气管扩张症中引发强烈炎症反应和肺功能损害。PA密度与大多数临床指标无关。PA感染与女性、频繁发作和囊状支气管扩张有关。

相似文献

1
Effect of airway Pseudomonas aeruginosa isolation and infection on steady-state bronchiectasis in Guangzhou, China.
J Thorac Dis. 2015 Apr;7(4):625-36. doi: 10.3978/j.issn.2072-1439.2015.04.04.
2
Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.
Int J Tuberc Lung Dis. 2015 May;19(5):610-9. doi: 10.5588/ijtld.14.0613.
3
Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations.
Respir Care. 2015 Aug;60(8):1180-9. doi: 10.4187/respcare.04004. Epub 2015 Jun 9.
4
Isolation of and risk factors for airway infection with Pseudomonas aeruginosa in patients with non-cystic fibrosis bronchiectasis.
J Bras Pneumol. 2021 Jun 23;47(3):e20210017. doi: 10.36416/1806-3756/e20210017. eCollection 2021.
5
[Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Apr 12;42(4):254-261. doi: 10.3760/cma.j.issn.1001-0939.2019.04.002.
6
Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.
Respir Med. 2017 Jul;128:1-6. doi: 10.1016/j.rmed.2017.05.001. Epub 2017 May 2.
7
Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.
Eur Respir J. 1996 Aug;9(8):1601-4. doi: 10.1183/09031936.96.09081601.
8
Altered community compositions of in adults with bronchiectasis.
Int J Chron Obstruct Pulmon Dis. 2018 Jul 17;13:2173-2182. doi: 10.2147/COPD.S159335. eCollection 2018.
9
Antibiotic-resistant infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications.
Int J Chron Obstruct Pulmon Dis. 2018 Jan 9;13:237-246. doi: 10.2147/COPD.S150250. eCollection 2018.
10
Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
Eur Respir J. 1997 Aug;10(8):1754-60. doi: 10.1183/09031936.97.10081754.

引用本文的文献

1
Phenotypes and endotypes in bronchiectasis: a narrative review of progress toward precision medicine.
J Thorac Dis. 2025 Apr 30;17(4):2640-2654. doi: 10.21037/jtd-2024-1945. Epub 2025 Apr 28.
2
Clinical Impacts of Isolation in Patients with Bronchiectasis: Findings from KMBARC Registry.
J Clin Med. 2024 Aug 24;13(17):5011. doi: 10.3390/jcm13175011.
3
Bacteria and viruses and clinical outcomes of asthma-bronchiectasis overlap syndrome: A cohort study.
Clin Transl Allergy. 2024 Jan;14(1):e12331. doi: 10.1002/clt2.12331.
4
Exercise Rehabilitation and Chronic Respiratory Diseases: Effects, Mechanisms, and Therapeutic Benefits.
Int J Chron Obstruct Pulmon Dis. 2023 Jun 19;18:1251-1266. doi: 10.2147/COPD.S408325. eCollection 2023.
5
The Distribution, Drug Susceptibility, and Dynamic Trends of Infection in a Tertiary Hospital in China During 2016‒2022.
Infect Drug Resist. 2023 Jun 3;16:3525-3533. doi: 10.2147/IDR.S408956. eCollection 2023.
6
Research advances and clinical management of bronchiectasis: Chinese perspective.
ERJ Open Res. 2022 Apr 11;8(2). doi: 10.1183/23120541.00017-2022. eCollection 2022 Apr.
7
Isolation of and risk factors for airway infection with Pseudomonas aeruginosa in patients with non-cystic fibrosis bronchiectasis.
J Bras Pneumol. 2021 Jun 23;47(3):e20210017. doi: 10.36416/1806-3756/e20210017. eCollection 2021.
8
Antibiotic-resistant infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications.
Int J Chron Obstruct Pulmon Dis. 2018 Jan 9;13:237-246. doi: 10.2147/COPD.S150250. eCollection 2018.
9
Evaluation of obstructive sleep apnea in non-cystic fibrosis bronchiectasis: A cross-sectional study.
PLoS One. 2017 Oct 3;12(10):e0185413. doi: 10.1371/journal.pone.0185413. eCollection 2017.

本文引用的文献

1
Impulse oscillometry in adults with bronchiectasis.
Ann Am Thorac Soc. 2015 May;12(5):657-65. doi: 10.1513/AnnalsATS.201406-280OC.
2
Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in bronchiectasis.
Int J Tuberc Lung Dis. 2014 Dec;18(12):1431-7. doi: 10.5588/ijtld.14.0195.
4
Capsaicin cough sensitivity and the association with clinical parameters in bronchiectasis.
PLoS One. 2014 Nov 19;9(11):e113057. doi: 10.1371/journal.pone.0113057. eCollection 2014.
5
Characterization of lung function impairment in adults with bronchiectasis.
PLoS One. 2014 Nov 18;9(11):e113373. doi: 10.1371/journal.pone.0113373. eCollection 2014.
6
Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.
Respir Med. 2014 Feb;108(2):287-96. doi: 10.1016/j.rmed.2013.12.015. Epub 2014 Jan 8.
8
The bronchiectasis severity index. An international derivation and validation study.
Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85. doi: 10.1164/rccm.201309-1575OC.
10
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score.
Eur Respir J. 2014 May;43(5):1357-67. doi: 10.1183/09031936.00026313. Epub 2013 Nov 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验